Analystreport

Soleno Therapeutics (NASDAQ:SLNO) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.

Soleno Therapeutics, Inc.  (SLNO) 
Last soleno therapeutics, inc. earnings: 5/13 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.soleno.life/investor-overview